Howard G. Smith seeks Embecta investors for securities fraud case

By Atlas Watchline Staff · Legal · August 10, 2026

Law Offices of Howard G. Smith says Embecta investors with losses may seek to lead a securities fraud class action before an Aug. 17 deadline.

Law Offices of Howard G. Smith says investors who lost money in Embecta Corp. may seek to lead a securities fraud class action before an Aug. 17, 2026 deadline.

The notice, published through PR Newswire on Aug. 10, 2026, says the firm is seeking investors with substantial losses in Embecta, which trades under the ticker EMBC. It says class members do not need to act immediately, but investors who want to be considered for lead-plaintiff status should contact the firm before the deadline.

The notice is an allegation notice, not a court ruling, and it does not include any response from Embecta.

According to the press release, the complaint alleges that between Nov. 25, 2025, and May 4, 2026, defendants made materially false or misleading statements and failed to disclose adverse facts about Embecta’s business, operations and prospects. The release says the suit claims the company’s guidance was misleading and unattainable.

The notice also alleges that segment weakness, especially in the U.S. pen needle market, was likely to disrupt Embecta’s original revenue guidance and its second-quarter 2026 results. It says the defendants’ positive statements lacked a reasonable basis.

The press release gives contact details for the Law Offices of Howard G. Smith in Bensalem, Pennsylvania, including a phone number, email address and website. It also says investors may retain counsel of their choice or remain absent class members.

The release says it may be considered attorney advertising in some jurisdictions. The lead-plaintiff deadline listed in the notice is Aug. 17.

Sources

• PR Newswire release: Embecta Corp. (EMBC) shareholders who lost money have opportunity to lead securities fraud lawsuit

Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.

This is the AMP version of the article. Read the full article on Atlas Watchline.